Variantyx
Framingham, US · Founded 2014 · Delaware corporation · 219 employees on LinkedIn · 9 known investors
Find your way into Variantyx
405 people in our graph share verified history with the Variantyx team — schools, employers, funds. One of them is your warm intro.
Paul Conwayunlockedknows Jeffrey Weisberg · together at Touche Ross (overlapped)
×3knows the team · via Fortress Investment Group
knows the team · via Texas A&M University
knows the team · via University of Massachusetts Amherst
×4knows the team · via AIG
×2knows the team · via Boston University School of Medicine
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology. It serves healthcare providers using proprietary laboratory technology and AI/ML analytical tools for genomic testing and personalized medicine.
Founders & leadership
Variantyx was founded in 2014 by Haim Neerman and Tomer Jackman.
HN
TJ
Tomer JackmaninCo-founder & VP Customer Support and Lab Services
JW
Jeffrey WeisberginChief Financial OfficerJeffrey Weisberg served as CEO and CFO of Athena Diagnostics from 1995 to 2014, leading the company's growth in neurology diagnostics before its $740M acquisition by Quest Diagnostics. He is currently CEO and President of ChipCare Corporation.
YR
Yaron RachmanyinOperations, R&D, IT (executive)
CS
Christine StanleyinChief Genomics and Compliance OfficerChristine Stanley is Chief Genomics and Compliance Officer at Variantyx, a molecular diagnostics company offering genetic testing for rare genetic disorders and precision oncology. She brings biotechnology industry experience in whole genome sequencing, variant interpretation, and molecular biology, with background as a CLIA-certified medical director.
ER
Eyal ReinsteininChief Medical Officer
TD
Tom DeLucainChief Human Resources OfficerTom DeLuca has held senior human resources leadership roles at Fortune 100 and private equity-backed companies, with experience in business strategy, organizational transformation, and talent management across mergers and acquisitions.
GF
Greg FaustNamed on SEC filing
Board
ZA
Zafrira AvnurBecame a director following financing closing.Advisory Board at 20/20 HealthCare Partners LLC
HB
NS
Noam ShomronWas a director at financing closing.
Investors · 9
20/20 HealthCare Partners LLC✓ verifiedAuburndale
Bosch Ventures✓ verifiedStuttgart · $27M
New Era Capital Partners✓ verifiedTel Aviv
OrbiMed✓ verifiedNew York · $1M – $75M
Peregrine Ventures✓ verifiedOr Yehuda · $500K – $3M
Pitango✓ verifiedTel Aviv · $4M – $100M
Quark Venture Inc.✓ verifiedVancouver
Soleus Capital✓ verifiedGreenwich
Robert Bosch Venture CapitalStuttgart · $1.6M – $27M
Funding
SEC filings, press & company announcements$51.6M disclosed across 2 of 3 rounds · 2021–2024
- $36MraisedApr 2024 · 3 sources
Bosch Ventures, New Era Capital Partners, Peregrine Ventures, Pitango HealthTech
Source ↗ - Undisclosed amountSeries CFeb 2022
New Era Capital partners (lead)
Source ↗
▶$15.6MraisedMar 2021 · 8 investors · Other TechnologyRule 506(b)
▶$15.6MraisedMar 2021 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Zafrira AvnurDirector
- Hillel BachrachDirector
- Noam ShomronDirector
- Greg FaustDirector
- Haim NeermanExecutive Officer, Director
- Offering amount
- $20.1M
- Amount sold
- $15.6M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
Labcorp149 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Quest Diagnostics130 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Myriad116 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
Genedx112 shared keywordsGeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.
Invitae110 shared keywordsInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
Sequencing75 shared keywordsSequencing.com offers free storage of personal DNA data along with tools and reports that turn genetic testing results into health-related insights for consumers. The company addresses data storage, usability, and privacy challenges created by widely available consumer genetic testing.
IDbyDNA73 shared keywordsScalable, high throughput DNA sequencing platforms.
Companies competing with Variantyx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Variantyx do?
- Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology. It serves healthcare providers using proprietary laboratory technology and AI/ML analytical tools for genomic testing and personalized medicine.
- Who founded Variantyx?
- Variantyx was founded by Haim Neerman, Tomer Jackman in 2014.
- Who are Variantyx's investors?
- Variantyx's investors include 20/20 HealthCare Partners LLC, Bosch Ventures, New Era Capital Partners, OrbiMed, Peregrine Ventures, Pitango, Quark Venture Inc., Soleus Capital and 1 more.
- How much funding has Variantyx raised?
- Variantyx has disclosed $51.6M raised across 2 of its 3 known rounds.
- Where is Variantyx headquartered?
- Variantyx is headquartered in Framingham, US.